Cytokine Imbalance as a Biomarker of Treatment-Resistant Schizophrenia

Treatment-resistant schizophrenia (TRS) is an important and unresolved problem in biological and clinical psychiatry. Approximately 30% of cases of schizophrenia (Sch) are TRS, which may be due to the fact that some patients with TRS may suffer from pathogenetically “non-dopamine” Sch, in the develo...

Descripción completa

Detalles Bibliográficos
Autores principales: Shnayder, Natalia A., Khasanova, Aiperi K., Strelnik, Anna I., Al-Zamil, Mustafa, Otmakhov, Andrey P., Neznanov, Nikolay G., Shipulin, German A., Petrova, Marina M., Garganeeva, Natalia P., Nasyrova, Regina F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570417/
https://www.ncbi.nlm.nih.gov/pubmed/36232626
http://dx.doi.org/10.3390/ijms231911324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570417/
https://www.ncbi.nlm.nih.gov/pubmed/36232626
http://dx.doi.org/10.3390/ijms231911324

Ejemplares similares